
    
      Research has suggested that high levels of erythropoietin (EPO) decreases the ability of
      infused umbilical cord stem cells to home to the bone marrow. The investigators will
      investigate the use of hyperbaric oxygen (HBO) therapy to decrease the plasma concentrations
      of EPO prior to UBC transplant and evaluate the resulting impact on UBC homing.
    
  